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Synthesis of and Characterization of Immunologically Active Glycosphingolipids 
Isolated from S. pneumoniae 
Carbohydrates fulfil many roles in biological systems including as structural supports, mediating cell 
signalling and acting as an energy supply. They also act as superantigens for the immune system when 
they are part of certain fat molecules called glycosphingolipids. These molecules are able to activate 
invariant Natural Killer T-Cells (iNKT cells), white blood cells that mount a dangerous non-specific 
systemic immune response that can potentially lead to death. However this same immune response, if 
controlled, has promise to act as a last line antiviral and/or a potential anticancer agent by potentially 
turning the immune system against previously ignored virus-infected or tumour cells. The Trant Team is 
making two such compounds recently isolated from pneumonia-causing bacteria; both have biological 
activity and bypass the non-polar lipid bilayer in the cells of the tissue they target. These compounds 
were first isolated in Streptococcus pneumonia, a dangerous bacterial species that may be responsible 
for the existence of these iNKT cells in all mammals. However neither compound has been thoroughly 
investigated, and only the simplest one has been made. Our more efficient synthesis, the nanoparticle 
self-assembly behaviour of these materials, and possibly the preliminary immunological results obtained 
by our collaborators (Haeryfar group Immunology, Western) will be presented. 
